Skip to main content

Table 5 Predictors of major study endpoints in multivariable analyses

From: Safety and efficacy of biocompatible perfusion strategy in a contemporary series of patients undergoing coronary artery bypass grafting – a two-center study

Variable

Odd ratio

95% confidence intervals

P value

A. 30-day mortality

Preoperative Immunosuppressive Therapy

12.98

2.38 – 70.8

0.003

Preoperative anti-arrhythmics

6.86

1.74 – 27.11

0.006

Left main disease

5.77

1.48 – 22.5

0.012

B. Allogeneic blood product transfusions

Age

1.05

1.03 – 1.06

<0.0001

Body surface area

1.004

1.00 – 1.007

0.025

Female gender

5.07

3.26 – 7.89

<0.000

Preoperative creatinine

1.65

1.15 – 2.36

0.007

LVEF

0.97

0.95 – 0.98

<0.0001

Preoperative hematocrit

0.85

0.81 – 0.88

<0.0001